Literature DB >> 28094181

The oxidative induction of DNA lesions in cancer cells by 5-thio-d-glucose and 6-thio-d-fructopyranose and their genotoxic effects. Part 3.

Anna Czubatka-Bienkowska1, Anna Macieja1, Joanna Sarnik1, Zbigniew J Witczak2, Tomasz Poplawski1.   

Abstract

Thio-sugars have been described as potent inhibitors of cancer cell growth but the detailed mechanism of action remains unknown. Herein we investigated the mechanism of their anticancer action in the HeLa cell line. We investigated two thio-sugars: 5-thio-d-glucose (FCP1) and 6-thio-β-d-fructopyranose (FCP2). We have observed that FCP1 as well as FCP2 clearly induced oxidative DNA lesions in cancer cells and increased the level of cellular ROS. A spin trap and antioxidants have decreased the level of DNA lesions induced by FCPs. FCPs also induced significant changes in the oxidative-stress gene expression. Therefore, we assume that ROS generation is correlated with the increased NOX5 expression by FCPs. Higher cyto- and genotoxicity of FCPs for HeLa cells in a low glucose environment suggested their role in the glucose metabolism. The data indicates that thio-sugars may become drug alternatives for the cancer treatment but such undertaking needs further studies.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  5-Thio-d-glucose; 6-Thio-d-fructopyranose; DNA damage; Functional CARB-pharmacophore; Oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28094181     DOI: 10.1016/j.bmcl.2017.01.011

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Effective targeting of breast cancer cells (MCF7) via novel biogenic synthesis of gold nanoparticles using cancer-derived metabolites.

Authors:  Sameh S M Soliman; Tasneem B Alhamidi; Shifaa Abdin; Ahmed M Almehdi; Mohammad H Semreen; Razan B Alhumaidi; Sarra B Shakartalla; Mohamed Haider; Mohamed I Husseiny; Hany A Omar
Journal:  PLoS One       Date:  2020-10-06       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.